Home › Eosinophilic Esophagitis › North Carolina
Eosinophilic Esophagitis clinical trials in North Carolina
3 studies for Eosinophilic Esophagitis are looking for participants at sites in North Carolina.
Cities in North Carolina
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University, Durham
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 6, 2026 · NCT07588568A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
- University of North Carolina, Bioinformatics Building, Chapel Hill
RecruitingPhase 3
6 Months – 6 Years · All sexes · Updated Sep 29, 2026 · NCT07112378OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
- University of North Carolina, Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 3 and older · All sexes · Updated Sep 12, 2025 · NCT02523118From ClinicalTrials.gov, data retrieved Oct 7, 2026. Each study sets its own eligibility; the study team decides who can join.